Nanjing Pharmaceutical to Acquire Majority Stakes in Three Jiangsu Subsidiaries
China-based Shanghai-listed Nanjing Pharmaceutical Co., Ltd (SHA: 600713) is set to acquire a respective 55%,...
MSD and Kelun Biotech Ink Record-Breaking ADC Deal
Merck, Sharp & Dohme (MSD, NYSE: MRK) has set a new benchmark for the largest...
NMPA and GAC Release Notification on Import and Export Management of Narcotic Drugs
The National Medical Products Administration (NMPA) and the General Administration of Customs (GAC) have released...
Shyndec’s Generic Cytosar-U Gains Marketing Approval in China
China-based Shanghai Shyndec Pharmaceutical Co., Ltd (SHA: 600420) has announced that its generic version of...
Sino Medical Sciences’ NC Rockstar Catheter Approved by US FDA
China-based Sino Medical Sciences Technology Inc. (SHA: 688108) has announced receiving market approval from the...
Antengene Files for Xpovio Approval in Macau, Malaysia, and Thailand
Antengene Corp., Ltd (HKG: 6996) has announced market filings for its Xpovio (selinexor) in Macau,...
Eisai and Biogen Initiate BLA in China for Alzheimer’s Therapy Lecanemab
Japan-based Eisai Co., Ltd (TYO: 4523) and its US co-development partner Biogen Inc. (NASDAQ: BIIB)...
Qitan Tech Raises RMB 700 Million in Series C Financing Led by Meituan
Qitan Tech, a nanopore gene sequencer maker based in Chengdu, has reportedly raised RMB 700...
Kanghong’s Escitalopram Oral Solution Receives NMPA Marketing Approval
China-based Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE: 002773) has announced receiving marketing approval from...
Tonghua Dongbao Receives NMPA Approval for THDBH151 Clinical Study in Gout and Hyperuricemia
China-based Tonghua Dongbao Pharmaceuticals (SHA: 600867) has announced receiving approval from the National Medical Products...
Innovent Biologics Announces Strategic Partnerships to Form Tumor Diagnosis and Treatment Alliance
China-based Innovent Biologics (HKG: 1801) has announced a series of strategic partnerships with compatriot firms...
BioNTech Ships First COVID-19 Vaccine Batches to China
BioNTech is reportedly in the process of shipping the first batches of its COVID-19 vaccines...
Merck Launches Noxafil in China for Antifungal Treatment
US-based Merck, Sharp & Dohme Inc. (MSD, NYSE: MRK) has announced the official market launch...
Hinova’s PROTAC Drug HP518 Accepted for FDA Review in mCRPC
China-based biopharma Hinova Pharmaceuticals has announced that a clinical trial filing for its androgen receptor...
Fosun Kite’s CAR-T Therapy FKC889 Approved for Clinical Trials in China
China-based Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has announced that its...
Shanghai Outlines Plans to Boost Healthcare and Pharma Industry
Liu Wei, director of the market orders and trade division of the Shanghai Commerce Commission,...
Yantai Dongcheng Receives NMPA Approval for F18 PET Imaging Study
China-based Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) has announced receiving approval from the...
Biomica Raises Funds for Tumor Immunity and IBD Drug Development
Israel-based start-up Biomica has reportedly raised an undisclosed amount of money via another financing round,...
Redpine Medical Raises ‘Hundreds of Millions’ in Series C Financing Round
Redpine Medical, a single-use endoscope maker based in Guangzhou, has reportedly raised “hundreds of millions”...
Yipinhong’s AR882 Receives NMPA Approval for Gout Clinical Trial
China-based Yipinhong Pharmacy Co., Ltd (SHA: 300723) has announced that its pipeline candidate AR882, under...